Endocrine, Metabolic & Immune Disorders - Drug Targets

Author(s): Hamid Ahanchian, Nasrin Moazzen*, Amin Saeidinia, Seyed H. Joghatayi, Maryam Khoshkhui, Mohammad H. Aelami, Nasrin S. M. Haghi and Nima Rezaei*

DOI: 10.2174/1871530320666201021142313

DownloadDownload PDF Flyer Cite As
Death Due to COVID-19 in an Infant with Combined Immunodeficiencies

Page: [1649 - 1652] Pages: 4

  • * (Excluding Mailing and Handling)

Abstract

Background: Severe Acute Respiratory Syndrome Coronavirus 2 has affected millions of people, and especially in adult patients with underlying diseases lead to death. Meanwhile pediatric patients with inherited defects of T cell should be prone to viral diseases.

Case Presentation: Herein, we report an infant with severe combined immunodeficiencies, who were affected and died because of COVID-19.

Conclusion: Considering the importance of finding how immune system can affect the viral infection, presentation of COVID-19 in immune deficient patients can be valuable.

Keywords: Combined immunodeficiency, COVID-19, cardiac injury, infant, death, bone marroow.